Intravenous Immunoglobulins
Mostrando 1-12 de 35 artigos, teses e dissertações.
-
1. Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil
ABSTRACT Introduction: The management of adult (≥18 years) immune thrombocytopenia patients relies on platelet count, the risk of bleeding and presence of bleeding. Objective: Confirming the diagnosis of immune thrombocytopenia and the start of therapy, our hematology service, a referral center, favors the establishment of this algorithm to treat those p
Hematol., Transfus. Cell Ther.. Publicado em: 10/10/2019
-
2. Endocarditis by Kocuria rosea in an immunocompetent child
Kocuria roseabelongs to genus Kocuria(Micrococcaceaefamily, suborder Micrococcineae, order Actinomycetales) that includes about 11 species of bacteria. Usually, Kocuria spare commensal organisms that colonize oropharynx, skin and mucous membrane; Kocuria spinfections have been described in the last decade commonly affecting immunocompromised patients, using
Braz J Infect Dis. Publicado em: 2015-02
-
3. O uso adjuvante da imunoglobulina endovenosa no tratamento da sepse neonatal: uma revisão sistemática com metanálise
OBJETIVO: Avaliar se a imunoglobulina endovenosa reduz a mortalidade e o tempo de internação no tratamento da sepse neonatal. FONTES DOS DADOS: A base de dados utilizada foi a MEDLINE. Os descritores, procurados por meio da ferramenta Medical Subject Headings, foram combinados na seguinte estratégia de busca: [(sepsis OR shock, septic OR infection) AND im
J. Pediatr. (Rio J.). Publicado em: 2012-10
-
4. Use of recombinant human IL-2 in patients with common variable immunodeficiency / Uso de IL-2 humana recombinante em pacientes com imunodeficiência comum variável
Na imunodeficiência comum variável (ICV) têm sido descritas alterações de linfócitos T, incluindo a produção diminuída da interleucina-2 (IL-2). Desde que a IL-2 pode promover a produção de imunoglobulinas in vitro, nosso principal objetivo foi investigar os efeitos in vivo do tratamento com IL-2 recombinante (IL-2r) em pacientes com ICV. Foram se
Publicado em: 2008
-
5. Recurrent pneumonia caused by genetic immunodeficiency: a prophylactic and rehabilitative approach
Recurrent infections are a consequence of a series of genetic diseases characterized by deficiency in the immunological response. One of these diseases is the agammaglobulinemia, which is characterized by the basic defect in the maturation of lymphocytes B. The carrier of this kind of immunodeficiency, which is linked to the X (XLA) chromosome, has had prima
Brazilian Journal of Infectious Diseases. Publicado em: 2007-06
-
6. Estudo comparativo in vitroentre preparações de imunoglobulina G, para uso intravenoso, obtidas de plasma humano de variadas procedências e processadas por diferentes técnicas de separação / "In vitro" comparative study between imunoglobulin G preparations, intravenous use, human plasma derived from different plasma sources and different separation techniques
A family of glicoproteins, which are called antibodies or immunoglobulins (IgG), mediates the protective effects of humoral immunity. In Brazil, the IgG for intravenous use are imported from other countries. The first Brazilian immunoglobulin G for therapheutic use was obtained from human plasma at the Fundação Pró-Sangue Hemocentro de São Paulo. The pre
Publicado em: 2001
-
7. Newer uses of intravenous immunoglobulins as anti-infective agents.
-
8. Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
-
9. Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
American Society for Microbiology.
-
10. Successful application of high dose intravenous immunoglobulins in Sjögren's syndrome associated arthritis.
-
11. Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study
BMJ Group.
-
12. Effective Combination Therapy for Invasive Pneumococcal Pneumonia with Ampicillin and Intravenous Immunoglobulins in a Mouse Model
Intranasal immunotherapy for Streptococcus pneumoniae invasive pneumonia with polyvalent immunoglobulins (IVIG) was effective in mice against pneumonia but failed to prevent bacteremia. The combination of subcurative doses of IVIG and of ampicillin was fully protective. Such an approach, successfully applied in the preantibiotic era, offers new perspectives
American Society for Microbiology.